2022-12-01 2023-11-30 false Capium Accounts Production 1.1 09856553 bus:AbridgedAccounts 2022-12-01 2023-11-30 09856553 bus:FRS102 2022-12-01 2023-11-30 09856553 bus:AuditExemptWithAccountantsReport 2022-12-01 2023-11-30 09856553 bus:SmallCompaniesRegimeForAccounts 2022-12-01 2023-11-30 09856553 bus:PrivateLimitedCompanyLtd 2022-12-01 2023-11-30 09856553 2022-12-01 2023-11-30 09856553 2023-11-30 09856553 bus:RegisteredOffice 2022-12-01 2023-11-30 09856553 core:WithinOneYear 2023-11-30 09856553 core:AfterOneYear 2023-11-30 09856553 bus:Director1 2022-12-01 2023-11-30 09856553 bus:Director1 2023-11-30 09856553 bus:Director1 2021-12-01 2022-11-30 09856553 2021-12-01 09856553 bus:LeadAgentIfApplicable 2022-12-01 2023-11-30 09856553 2021-12-01 2022-11-30 09856553 2022-11-30 09856553 core:WithinOneYear 2022-11-30 09856553 core:AfterOneYear 2022-11-30 09856553 bus:EntityAccountantsOrAuditors 2021-12-01 2022-11-30 09856553 core:LandBuildings 2022-12-01 2023-11-30 09856553 core:LandBuildings 2023-11-30 09856553 core:LandBuildings 2022-11-30 09856553 core:FurnitureFittings 2022-12-01 2023-11-30 09856553 core:FurnitureFittings 2023-11-30 09856553 core:FurnitureFittings 2022-11-30 09856553 core:ComputerEquipment 2022-12-01 2023-11-30 09856553 core:ComputerEquipment 2023-11-30 09856553 core:ComputerEquipment 2022-11-30 09856553 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-11-30 09856553 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2022-11-30 09856553 core:NetGoodwill 2022-12-01 2023-11-30 09856553 core:NetGoodwill 2023-11-30 09856553 core:NetGoodwill 2022-11-30 09856553 core:CostValuation core:Non-currentFinancialInstruments 2023-11-30 09856553 core:CostValuation core:Non-currentFinancialInstruments 2022-11-30 09856553 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2023-11-30 09856553 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2023-11-30 09856553 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2023-11-30 09856553 core:Non-currentFinancialInstruments 2023-11-30 09856553 core:Non-currentFinancialInstruments 2022-11-30 09856553 core:ShareCapital 2023-11-30 09856553 core:ShareCapital 2022-11-30 09856553 core:RetainedEarningsAccumulatedLosses 2023-11-30 09856553 core:RetainedEarningsAccumulatedLosses 2022-11-30 09856553 dpl:Item1 2022-12-01 09856553 dpl:Item1 2023-11-30 09856553 dpl:Item1 2021-12-01 09856553 dpl:Item1 2022-11-30 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 09856553
England and Wales

 

 

 

ALPHADRUGS LIMITED


Abridged Accounts
 


Period of accounts

Start date: 01 December 2022

End date: 30 November 2023
Report to the directors on the preparation of the unaudited statutory accounts of Alphadrugs Limited for the year ended 30 November 2023
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Alphadrugs Limited for the year ended 30 November 2023 which comprise of the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the company’s accounting records and from information and explanations you have given us
As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at
http://rulebook.accaglobal.com/
This report is made solely to the Board of Directors of Alphadrugs Limited, as a body, in accordance with the terms of our engagement letter dated 30 August 2024 Our work has been undertaken solely to prepare for your approval the accounts of Alphadrugs Limited and state those matters that we have agreed to state to the Board of Directors of Alphadrugs Limited, as a body, in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at http://www.accaglobal.com/factsheet163. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Alphadrugs Limited and its Board of Directors as a body for our work or for this report.
It is your duty to ensure that Alphadrugs Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of Alphadrugs Limited. You consider that Alphadrugs Limited is exempt from the statutory audit requirement for the year
We have not been instructed to carry out an audit or a review of the accounts of Alphadrugs Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts
30 November 2023



....................................................
Martin Morrison & Co Limited
Martin Morrison & Co Limited

Unit 43 The Coach House
66-70 Bourne Road
Bexley
DA5 1LU
30 August 2024
1
 
 
Notes
 
2023
£
  2022
£
Fixed assets      
Intangible fixed assets 3 210,978    228,559 
Tangible fixed assets 4 20,000    30,000 
230,978    258,559 
Current assets      
Stocks 14,003    16,504 
Debtors 26,990    32,817 
Cash at bank and in hand (13,846)   (2,276)
27,147    47,045 
Creditors: amount falling due within one year (43,374)   (41,293)
Net current assets (16,227)   5,752 
 
Total assets less current liabilities 214,751    264,311 
Creditors: amount falling due after more than one year (256,002)   (298,912)
Net assets (41,251)   (34,601)
 

Capital and reserves
     
Called up share capital 100    100 
Profit and loss account (41,351)   (34,701)
Shareholders' funds (41,251)   (34,601)
 


For the year ended 30 November 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006 the profit and loss account has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the director on 30 August 2024 and were signed by:


-------------------------------
Adewale Samuel Anigilaje
Director
2
General Information
Alphadrugs Limited is a private company, limited by shares, registered in England and Wales, registration number 09856553, registration address 29 High Street, Kimbolton, Huntingdon, Cambridgeshire, PE28 0HB.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by Section 1A of the standard)
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Intangible assets
Intangible assets (including purchased goodwill and patents) are amortised at rates calculated to write off the assets on a straight line basis over their estimated useful economic lives. Impairment of intangible assets is only reviewed where circumstances indicate that the carrying value of an asset may not be fully recoverable.
Goodwill
Acquired goodwill is stated at cost less amortisation. Amortisation is calculated on a straight line basis over the estimated expected useful economic life of the goodwill of [20] years.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Land and Buildings 10 Reducing Balance
Fixtures and Fittings 25% Straight Line
Computer Equipment 25% Straight Line
Stocks
Stocks are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow moving items. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads.
2.

Average number of employees

Average number of employees during the year was 3 (2022 : 3).
3.

Intangible fixed assets

Cost Goodwill   Total
  £   £
At 01 December 2022 351,627    351,627 
Additions  
Disposals  
At 30 November 2023 351,627    351,627 
Amortisation
At 01 December 2022 123,068    123,068 
Charge for year 17,581    17,581 
On disposals  
At 30 November 2023 140,649    140,649 
Net book values
At 30 November 2023 210,978    210,978 
At 30 November 2022 228,559    228,559 


4.

Tangible fixed assets

Cost or valuation Land and Buildings   Fixtures and Fittings   Computer Equipment   Total
  £   £   £   £
At 01 December 2022 100,000    10,251    660    110,911 
Additions      
Disposals      
At 30 November 2023 100,000    10,251    660    110,911 
Depreciation
At 01 December 2022 70,000    10,252    659    80,911 
Charge for year 10,000        10,000 
On disposals      
At 30 November 2023 80,000    10,252    659    90,911 
Net book values
Closing balance as at 30 November 2023 20,000    (1)   1    20,000 
Opening balance as at 01 December 2022 30,000    (1)   1    30,000 


3